TA
GYRE icon

Teachers Advisors’s Gyre Therapeutics GYRE Stock Holding History

Teachers Advisors’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$184K Hold
3,033
– – ﹤0.01% 2857
2018
Q4 		$179K Buy
3,033
+927
+44% +$68.4K ﹤0.01% 2870
2018
Q3 		$170K Hold
2,106
– – ﹤0.01% 2968
2018
Q2 		$184K Buy
+2,106
New +$369K ﹤0.01% 3005
2014
Q3 		– Hold
0
– -$1K – 3128
2014
Q2 		– Sell
-60
Closed -$196K – 3105
2014
Q1 		$225K Hold
60
– – ﹤0.01% 2820
2013
Q4 		$196K Buy
60
+9
+18% +$35.5K ﹤0.01% 2870
2013
Q3 		$214K Sell
51
-1
-2% -$4.02K ﹤0.01% 2786
2013
Q2 		$173K Buy
+52
New +$198K ﹤0.01% 2845

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Teachers Advisors's GYRE Position: Q1 2019 in Review

Teachers Advisors held its Gyre Therapeutics (GYRE) position steady in Q1 2019 at 3,033 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2857.

Teachers Advisors first reported a position in GYRE in Q2 2013 and has held it in 8 quarters since. The position peaked at $225K in Q1 2014. 63 funds tracked by Wall St. Rank hold GYRE as of Q1 2019.

  • Teachers Advisors held 3,033 shares of Gyre Therapeutics worth $184K as of Q1 2019.
  • Teachers Advisors left its Gyre Therapeutics share count unchanged in Q1 2019.
  • Gyre Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2857 holding.
  • Teachers Advisors first reported a position in Gyre Therapeutics in Q2 2013 and has held it in 8 quarters since.
  • Teachers Advisors's Gyre Therapeutics position peaked at $225K in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.